ImmVira’s New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

SHENZHEN, China, Jan. 25, 2022 /PRNewswire/ -- Demonstrating innovation leadership on a global level, ImmVira announced that, its custom-designed new-generation oncolytic herpes simplex virus ("oHSV") vector ...

Full "IntellAsia: Resources" article